An­oth­er biotech shuf­fles its C-suite as Si­lence CEO steps down

Si­lence Ther­a­peu­tics be­came the lat­est biotech to see its chief ex­ec­u­tive hit the ex­it.

Mark Rothera is leav­ing ef­fec­tive im­me­di­ate­ly, Si­lence an­nounced late Mon­day, mark­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER